Skip to main content

Table 5 Haplotype frequency of the LTA and TNFA genes SNPs in COPD patients vs. Healthy control individuals

From: TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study

 

Haplotypes*

Total freq.

Healthy controls n = 432

COPD cases n = 199

ORadj (95%CI)ª

p-value

1

A A T C C C G G G G

0.2827

0.2806

0.2982

1.00

 

2

C A C C A C G G G G

0.1703

0.1815

0.1461

0.70 (0.45 - 1.08)

0.11

3

C G T A C C G A G G

0.1311

0.1328

0.1220

1.03 (0.64 - 1.66)

0.90

4

C G T A C C G G G G

0.1268

0.1280

0.1257

1.09 (0.67 - 1.78)

0.72

5

C A C C C C G G G G

0.0806

0.0723

0.0944

1.27 (0.72 - 2.23)

0.40

6

A A T C C T G G G A

0.0762

0.0749

0.0781

1.33 (0.76 - 2.35)

0.32

7

C A C C C C A G A G

0.0251

0.0205

0.0327

1.74 (0.75 - 4.00)

0.19

8

C A C C C C G G A G

0.0202

0.0196

0.0212

1.54 (0.59 - 4.02)

0.38

9

C A T C C C G G G G

0.0165

0.0177

0.0139

1.59 (0.56 - 4.48)

0.38

10

Rare

0.0703

    
  1. *Haplotypes: LT+49, LT+252, LT+495, LT+720, TNF-863, TNF-857, TNF-376, TNF-308, TNF-238, TNF+489.
  2. ª ORadj: odds ratio adjusted by age and gender; CI: confidence interval.